Literature DB >> 14212116

STUDIES ON THE MECHANISMS OF HYPERSENSITIVITY PHENOMENA. IX. HISTAMINE RELEASE FROM HUMAN LEUKOCYTES BY RAGWEED POLLEN ANTIGEN.

L M LICHTENSTEIN, A G OSLER.   

Abstract

Human leukocytes, isolated from the blood of ragweed-sensitive donors, release histamine upon reaction with a purified protein antigen derived from this pollen. The release process has been studied with washed cells suspended in a defined, serum-free medium. Physiologic levels of pH, ionic strength, and temperature, as well as both calcium and magnesium, are required for optimal cellular reactivity. The level of cellular sensitivity of approximately 200 ragweed-sensitive donors has been ascertained, and the kinetics of the release process studied. The rate of histamine release is a function of antigen concentration, but even with a large excess of this reagent it is impossible to abolish a lag phase. Chelation of the divalent cations or a decrease in the reaction temperature may be utilized to stop the reaction. These measures are effective both before and after the initiation of histamine release. Diminished cellular reactivity (desensitization) has been achieved by several procedures. These have in common the addition of antigen to cells in an environment deficient in but a single respect, followed by a restoration of optimal conditions. The significance of these data has been discussed and it has been proposed that immunologically induced histamine release is an active, enzymatically mediated process which occurs as a multistep response of viable cells to a specific antigenic stimulus.

Entities:  

Keywords:  ANTIGENS; CALCIUM; EXPERIMENTAL LAB STUDY; HISTAMINE LIBERATION; HYDROGEN-ION CONCENTRATION; HYPERSENSITIVITY; LEUKOCYTES; MAGNESIUM; PHARMACOLOGY; POLLEN; PROTEINS; TEMPERATURE

Mesh:

Substances:

Year:  1964        PMID: 14212116      PMCID: PMC2137776          DOI: 10.1084/jem.120.4.507

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  15 in total

1.  The release of histamine from rabbit platelets by means of antigen-antibody precipitates. I. The participation of the immune complex in histamine release.

Authors:  J F BARBARO
Journal:  J Immunol       Date:  1961-04       Impact factor: 5.422

2.  Distribution of histamine among leukocytes and platelets.

Authors:  H T GRAHAM; O H LOWRY; F WHEELWRIGHT; M A LENZ; H H PARISH
Journal:  Blood       Date:  1955-05       Impact factor: 22.113

3.  The effect of hyposensitization on the in vitro histamine release by specific antigen.

Authors:  P P VANARSDEL; E MIDDLETON
Journal:  J Allergy       Date:  1961 Jul-Aug

4.  An improved method for isolating viable human leukocytes from peripheral blood.

Authors:  J H LAPIN; A HORONICK; R H LAPIN
Journal:  Blood       Date:  1958-10       Impact factor: 22.113

5.  A quantitative study on the in vitro release of histamine from leukocytes of atopic persons.

Authors:  P P VANARSDEL; E MIDDLETON; W B SHERMAN; H BUCHWALD
Journal:  J Allergy       Date:  1958-09

6.  Determination of cell viability.

Authors:  J H HANKS; J H WALLACE
Journal:  Proc Soc Exp Biol Med       Date:  1958-05

7.  Correlation of blood histamine release and skin test response to multiple antigens.

Authors:  J W NOAH; A BRAND
Journal:  J Allergy       Date:  1955-09

8.  Release of histamine in the blood of ragweed-sensitive individuals.

Authors:  J W NOAH; A BRAND
Journal:  J Allergy       Date:  1954-05

9.  Cellular mechanisms in anaphylaxis.

Authors:  J L MONGAR; H O SCHILD
Journal:  Physiol Rev       Date:  1962-04       Impact factor: 37.312

10.  Studies on the mechanism of hypersensitivity phenomena. III. The participation of complement in the formation of anaphylatoxin.

Authors:  A G OSLER; H G RANDALL; B M HILL; Z OVARY
Journal:  J Exp Med       Date:  1959-08-01       Impact factor: 14.307

View more
  132 in total

1.  Ionic regulation of human basophil releasability. I. Inhibitory effect of copper.

Authors:  A Tedeschi; M Arquati; M Lorini; N Milazzo; A Miadonna
Journal:  Agents Actions       Date:  1992-09

2.  IMMUNOLOGIC ASPECTS OF HUMAN REAGINIC ALLERGY: AN IN VITRO METHOD AND SOME APPLICATIONS.

Authors:  A G OSLER; L M LICHTENSTEIN; D A LEVY
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1965-02-16

Review 3.  Diagnosis of mold allergy.

Authors:  H J Malling
Journal:  Clin Rev Allergy       Date:  1992

4.  Low MW B-cell growth factor potentiates histamine release from human basophil leucocytes.

Authors:  A Tedeschi; M G Roncarolo; M Lorini; A Miadonna
Journal:  Immunology       Date:  1991-06       Impact factor: 7.397

5.  In vitro studies of human ragweed allergy: changes in cellular and humoral activity associated with specific desensitization.

Authors:  L M Lichtenstein; P S Norman; W L Winkenwerder; A G Osler
Journal:  J Clin Invest       Date:  1966-07       Impact factor: 14.808

6.  A pH-stabilizing role of voltage-gated proton channels in IgE-mediated activation of human basophils.

Authors:  Boris Musset; Deri Morgan; Vladimir V Cherny; Donald W MacGlashan; Larry L Thomas; Eduardo Ríos; Thomas E DeCoursey
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-29       Impact factor: 11.205

7.  Serum reagins and leucocyte response in patients with house-dust mite allergy.

Authors:  E S Assem; M K McAllen
Journal:  Br Med J       Date:  1970-05-30

8.  Defective histamine release in chronic urticaria.

Authors:  F Kern; L M Lichtenstein
Journal:  J Clin Invest       Date:  1976-05       Impact factor: 14.808

9.  IgA and IgG anti-ragweed antibodies in nasal secretions. Quantitative measurements of antibodies and correlation with inhibition of histamine release.

Authors:  T A Platts-Mills; R K von Maur; K Ishizaka; P S Norman; L M Lichtenstein
Journal:  J Clin Invest       Date:  1976-04       Impact factor: 14.808

10.  IgE receptors on human basophils. Relationship to serum IgE concentration.

Authors:  F J Malveaux; M C Conroy; N F Adkinson; L M Lichtenstein
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.